Syneos Health Inc. Cl A

NAS: SYNH

GO
/marketstate/country/us

Market open

 --Real time quotes

Aug 13, 2020, 11:17 a.m.

/zigman2/quotes/207981284/composite

$

63.30

Change

-0.62 -0.97%

Volume

Volume 53,716

Real time quotes

/zigman2/quotes/207981284/composite

Previous close

$ 63.92

$ 63.30

Change

-0.62 -0.97%

Day low

Day high

$63.15

$63.88

Open

52 week low

52 week high

$30.02

$74.25

Open

Insider Actions for Syneos Health Inc. Cl A

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
08/03/2020 Alistair John Macdonald
Chief Executive Officer; Director
10,289   Disposition at $65.07 per share. 669,505
08/03/2020 Alistair John Macdonald
Chief Executive Officer; Director
4,178   Derivative/Non-derivative trans. at $65.06 per share. 271,820
07/15/2020 Alistair John Macdonald
Chief Executive Officer; Director
9,467   Disposition at $60.14 per share. 569,345
07/15/2020 Alistair John Macdonald
Chief Executive Officer; Director
9,467   Disposition at $60.14 per share. 569,345
07/15/2020 Alistair John Macdonald
Chief Executive Officer; Director
18,934   Disposition at $60.14 per share. 1,138,690
07/15/2020 Alistair John Macdonald
Chief Executive Officer; Director
9,467   Derivative/Non-derivative trans. at $16.06 per share. 152,040
07/15/2020 Alistair John Macdonald
Chief Executive Officer; Director
9,467   Derivative/Non-derivative trans. at $16.06 per share. 152,040
07/15/2020 Alistair John Macdonald
Chief Executive Officer; Director
18,934   Derivative/Non-derivative trans. at $16.06 per share. 304,080
07/14/2020 Alistair John Macdonald
Chief Executive Officer; Director
373   Disposition at $59.15 per share. 22,062
07/14/2020 Alistair John Macdonald
Chief Executive Officer; Director
4,800   Disposition at $58.64 per share. 281,472
07/14/2020 Alistair John Macdonald
Chief Executive Officer; Director
5,173   Derivative/Non-derivative trans. at $10.57 per share. 54,678
07/13/2020 Alistair John Macdonald
Chief Executive Officer; Director
3,655   Disposition at $58.21 per share. 212,757
07/13/2020 Alistair John Macdonald
Chief Executive Officer; Director
3,655   Derivative/Non-derivative trans. at $10.57 per share. 38,633
07/06/2020 Michelle Keefe
Pres., Commercial Solutions
1,500   Disposition at $59.11 per share. 88,665
07/06/2020 John M. Dineen
Director
8,691   Acquisition at $59.11 per share. 513,725
05/27/2020 Thomas H. Lee Partners LP
Director
2,803   Award at $0 per share. 0
05/27/2020 Thomas H. Lee Partners LP
Director
2,803   Award at $0 per share. 0
05/27/2020 Thomas H. Lee Partners LP
Director
2,803   Award at $0 per share. 0
05/27/2020 Thomas H. Lee Partners LP
Director
2,803   Award at $0 per share. 0
05/27/2020 John M. Dineen
Director
2,803   Award at $62.43 per share. 174,991
05/27/2020 Kenneth F. Meyers
Director
2,803   Award at $62.43 per share. 174,991
05/27/2020 Matthew E. Monaghan
Director
2,803   Award at $62.43 per share. 174,991
05/27/2020 William E. Klitgaard
Director
2,803   Award at $62.43 per share. 174,991
05/27/2020 Linda A. Harty
Director
2,803   Award at $62.43 per share. 174,991
05/27/2020 Bernadette M. Connaughton
Director
2,803   Award at $62.43 per share. 174,991
05/20/2020 Michelle Keefe
Pres., Commercial Solutions
2,500   Disposition at $60 per share. 150,000
04/20/2020 Robert Alan Parks
EVP, Chief Accounting Officer
3,588   Disposition at $49.65 per share. 178,144
04/20/2020 Robert Alan Parks
EVP, Chief Accounting Officer
377   Award at $44.48 per share. 16,768
03/20/2020 Jason Michael Meggs
Chief Financial Officer
45   Acquisition at $36 per share. 1,620
03/20/2020 Jason Michael Meggs
Chief Financial Officer
3,510   Acquisition at $36.75 per share. 128,992
03/19/2020 Paul D. Colvin
Pres., Clinical Solutions
1,300   Acquisition at $36.65 per share. 47,645

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
16 Purchases
10 Sales
83,417
65,163
Last 6 months
29 Purchases
14 Sales
155,271
85,769
Last 12 months
36 Purchases
29 Sales
254,304
120,083

Officers and Executives

Mr. Alistair John Macdonald
Chief Executive Officer & Director
Mr. Jason Michael Meggs
Chief Financial Officer & Executive Vice President
Ms. Michelle Keefe
President-Commercial Solutions
Mr. Paul D. Colvin
President-Clinical Solutions
Mr. Neil Ferguson
Chief Business Officer
Mr. Mark Dmytruk
Executive VP-Corporate Strategy & Development
Ms. Kristen Spensieri
Head- Global Communications & Marketing
Mr. Robert Alan Parks
Chief Accounting Officer & Executive VP
Mr. Ronnie Speight
Senior Vice President-Investor Relations
Ms. Lisa van Capelle
Chief Human Resources Officer
Mr. Jonathan Olefson
Secretary & General Counsel
Mr. John M. Dineen
Chairman
Ms. Bernadette M. Connaughton
Independent Director
Mr. Matthew E. Monaghan
Independent Director
Mr. Kenneth F. Meyers
Independent Director
Mr. Thomas Alexander Allen
Independent Director
Mr. Todd M. Abbrecht
Independent Director
Mr. William E. Klitgaard
Independent Director
Mr. John L. Maldonado
Independent Director
Mr. Joshua M. Nelson
Independent Director
Ms. Linda A. Harty
Independent Director
Link to MarketWatch's Slice.